Preferred Name |
Doripenem |
|
Synonyms |
DORIPENEM Doribax Doripenem FInibax S-4661 |
|
Definitions |
A broad-spectrum, carbapenem antibiotic with bactericidal and beta-lactamase resistant activities. Doripenem binds to penicillin binding proteins (PBPs) located on the bacterial cell wall, particularly PBPs 2 and 3, thereby inhibiting the final transpeptidation step in the synthesis of peptidoglycan, an essential component of the bacterial cell wall. Inhibition results in a weakening and eventually lysis of the bacterial cell wall. This agent is two- to 16-fold more potent than imipenem and comparable to ertapenem and meropenem. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C65470 |
|
Accepted_Therapeutic_Use_For |
Intraabdominal Infection, Urinary Tract Infection |
|
CAS_Registry |
148016-81-3 |
|
Chemical_Formula |
C15H24N4O6S2 |
|
code |
C65470 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A broad-spectrum, carbapenem antibiotic with bactericidal and beta-lactamase resistant activities. Doripenem binds to penicillin binding proteins (PBPs) located on the bacterial cell wall, particularly PBPs 2 and 3, thereby inhibiting the final transpeptidation step in the synthesis of peptidoglycan, an essential component of the bacterial cell wall. Inhibition results in a weakening and eventually lysis of the bacterial cell wall. This agent is two- to 16-fold more potent than imipenem and comparable to ertapenem and meropenem. |
|
FDA_UNII_Code |
BHV525JOBH |
|
FULL_SYN |
DORIPENEM Doribax Doripenem FInibax S-4661 |
|
label |
Doripenem |
|
Legacy Concept Name |
Doripenem |
|
Preferred_Name |
Doripenem |
|
prefixIRI |
Thesaurus:C65470 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0389169 |
|
subClassOf |